| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 20.550 | 11.655 | 7.156 | 12.635 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 26.888 | 11.655 | 7.156 | 28.878 | 0 |
| Total Expenses - EUR | - | - | - | - | 2.128 | 24.326 | 9.006 | 6.595 | 12.124 | 13.292 |
| Gross Profit/Loss - EUR | - | - | - | - | -2.128 | 2.562 | 2.649 | 560 | 16.754 | -13.292 |
| Net Profit/Loss - EUR | - | - | - | - | -2.128 | 2.357 | 2.302 | 346 | 16.466 | -13.292 |
| Employees | - | - | - | - | 1 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Topkatina Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 32.843 | 27.685 | 23.698 | 19.196 | 14.684 |
| Current Assets | - | - | - | - | 27.758 | 16.481 | 24.153 | 24.871 | 34.931 | 27.600 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 19.623 | 16.243 | 23.899 | 22.006 | 33.745 | 26.819 |
| Cash | - | - | - | - | 8.135 | 238 | 253 | 2.865 | 1.185 | 781 |
| Shareholders Funds | - | - | - | - | -2.086 | 311 | 2.606 | 2.960 | 19.417 | 6.017 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.663 | 12.153 | 13.189 | 9.453 | 14.908 | 16.575 |
| Income in Advance | - | - | - | - | 28.180 | 36.861 | 36.044 | 36.155 | 19.803 | 19.692 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2041 - 2041" | |||||||||
| CAEN Financial Year |
2041
|
|||||||||
Comments - Topkatina Bio S.r.l.